Stati Uniti - Ingliż - NLM (National Library of Medicine)

bi-coastal pharma international llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - sodium sulfacetamide 10% and sulfur 2% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 10% and sulfur 2% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% and sulfur 2% cleanser is not to be used by patients with kidney disease.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 80 mg in 1 ml - sodium sulfacetamide 8% - sulfur 4% topical suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 8% - sulfur 4% topical suspension is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 8% - sulfur 4% topical suspension is not to be used by patients with kidney disease. safety and effectiveness in children under the age of 12 have not been established.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

trinity pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 9 mg in 1 g - sodium sulfacetamide 9% & sulfur 4.5% wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 9% & sulfur 4.5% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 9% & sulfur 4.5% wash is not to be used by patients with kidney disease.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sodium nitrite, quantity: 30 mg/ml - injection, solution - excipient ingredients: water for injections - dbl sodium nitrite injection is indicated as an antidote in the treatment of cyanide poisoning, in conjunction with sodium thiosulfate.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sodium sulfacetamide 10% wash is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). it is also indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. sodium sulfacetamide 10% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides or any other component of this product. safety and effectiveness in children under the age of 12 have not been established.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - sodium thiosulfate pentahydrate 500mg equivalent to 10 % w/v, as pentahydrate - solution for injection - 10 % - active: sodium thiosulfate pentahydrate 500mg equivalent to 10 % w/v, as pentahydrate excipient: dibasic sodium phosphate dodecahydrate sodium metabisulfite water for injection

Stati Uniti - Ingliż - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 100 mci - sodium iodide i 131 capsules diagnostic is indicated for use in adults for: - assessment of thyroid function using radioactive iodine (rai) uptake test - imaging the thyroid (scintigraphy) sodium iodide i 131 capsules diagnostic is contraindicated in pregnancy [see warnings and precautions (5.1) , use in specific populations (8.1) ]. risk summary sodium iodide i 131 capsules diagnostic is contraindicated in pregnancy because fetal exposure can lead to neonatal hypothyroidism, which in some cases is severe and irreversible. data from the published literature describe reports of neonatal thyroid abnormalities after fetal exposure, including agenesis of the thyroid and hypothyroidism (see clinical considerations, data ). no animal reproductive studies have been conducted. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnanc

Stati Uniti - Ingliż - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 10 g in 100 g - indications: sodium sulfacetamide 10% - sulfur 4% cleansing pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% - sulfur 4% cleansing pads are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 10% - sulfur 4% cleansing pads are not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 have not been established.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sodium sulfacetamide 10% and sulfur 5% cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 10% and sulfur 5% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% and sulfur 5% cleanser is not to be used by patients with kidney disease.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

e. fougera & co., a division of nycomed us inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g - sodium sulfacetamide medicated pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide medicated pads are contraindicated in persons with known or suspected hypersensitivity to sulfonamides or to any of the ingredients of the preparation. sodium sulfacetamide medicated pads are not to be used by patients with kidney disease.